Omniscan intelligence · 1 October 2026–31 October 2026

UK pharma media reputation tracker

Compare share of voice, sentiment and themes for GSK, AstraZeneca, Pfizer and 7 peers across 934 UK earned-media mentions, Oct–Oct 2026.

Reporting period
1 October 2026–31 October 2026
Articles analysed
1,122
Earned-media mentions
934
Organisations compared
10

Organisations in the benchmark

What the benchmark compares

Explore share of voice, monthly visibility, coverage volume, positive and negative sentiment, net media tone and editorial themes. Compare the full cohort, then open an organisation-level deep dive for its news-cycle movement, leading themes and coverage evidence.

AstraZeneca led average share of voice at 31.2%.